Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1983 Apr 15;128(8):915–917.

Management of the febrile neutropenic patient.

L A Mandell
PMCID: PMC1875409  PMID: 6831337

Full text

PDF
915

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alavi J. B., Root R. K., Djerassi I., Evans A. E., Gluckman S. J., MacGregor R. R., Guerry D., Schreiber A. D., Shaw J. M., Koch P. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977 Mar 31;296(13):706–711. doi: 10.1056/NEJM197703312961302. [DOI] [PubMed] [Google Scholar]
  2. Dekker A. W., Rozenberg-Arska M., Sixma J. J., Verhoef J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med. 1981 Nov;95(5):555–559. doi: 10.7326/0003-4819-95-5-555. [DOI] [PubMed] [Google Scholar]
  3. FORKNER C. E., Jr, FREI E., 3rd, EDGCOMB J. H., UTZ J. P. Pseudomonas septicemia; observations on twenty-three cases. Am J Med. 1958 Dec;25(6):877–889. doi: 10.1016/0002-9343(58)90060-3. [DOI] [PubMed] [Google Scholar]
  4. Gurwith M. J., Brunton J. L., Lank B. A., Harding G. K., Ronald A. R. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med. 1979 Feb;66(2):248–256. doi: 10.1016/0002-9343(79)90539-4. [DOI] [PubMed] [Google Scholar]
  5. Herzig R. H., Herzig G. P., Graw R. G., Jr, Bull M. I., Ray K. K. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med. 1977 Mar 31;296(13):701–705. doi: 10.1056/NEJM197703312961301. [DOI] [PubMed] [Google Scholar]
  6. Higby D. J., Yates J. W., Henderson E. S., Holland J. F. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975 Apr 10;292(15):761–766. doi: 10.1056/NEJM197504102921501. [DOI] [PubMed] [Google Scholar]
  7. Lau W. K., Young L. S., Black R. E., Winston D. J., Linne S. R., Weinstein R. J., Hewitt W. L. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail. Am J Med. 1977 Jun;62(6):959–966. doi: 10.1016/0002-9343(77)90669-6. [DOI] [PubMed] [Google Scholar]
  8. Love L. J., Schimpff S. C., Hahn D. M., Young V. M., Standiford H. C., Bender J. F., Fortner C. L., Wiernik P. H. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. Am J Med. 1979 Apr;66(4):603–610. doi: 10.1016/0002-9343(79)91170-7. [DOI] [PubMed] [Google Scholar]
  9. Pizzo P. A., Robichaud K. J., Gill F. A., Witebsky F. G. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med. 1982 Jan;72(1):101–111. doi: 10.1016/0002-9343(82)90594-0. [DOI] [PubMed] [Google Scholar]
  10. Pizzo P. A., Robichaud K. J., Gill F. A., Witebsky F. G., Levine A. S., Deisseroth A. B., Glaubiger D. L., Maclowry J. D., Magrath I. T., Poplack D. G. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug;67(2):194–200. doi: 10.1016/0002-9343(79)90390-5. [DOI] [PubMed] [Google Scholar]
  11. Schimpff S. C., Greene W. H., Young V. M., Fortner C. L., Cusack N., Block J. B., Wiernik P. H. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975 Mar;82(3):351–358. doi: 10.7326/0003-4819-82-3-351. [DOI] [PubMed] [Google Scholar]
  12. Schimpff S. C., Greene W. H., Young V. M., Wiernik P. H. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis. 1974 Nov;130 (Suppl)(0):S24–S31. doi: 10.1093/infdis/130.supplement.s24. [DOI] [PubMed] [Google Scholar]
  13. Sickles E. A., Greene W. H., Wiernik P. H. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975 May;135(5):715–719. [PubMed] [Google Scholar]
  14. Storring R. A., Jameson B., McElwain T. J., Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977 Oct 22;2(8043):837–840. doi: 10.1016/s0140-6736(77)90779-6. [DOI] [PubMed] [Google Scholar]
  15. Whitecar J. P., Jr, Luna M., Bodey G. P. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci. 1970 Oct;60(4):216–223. doi: 10.1097/00000441-197010000-00003. [DOI] [PubMed] [Google Scholar]
  16. Wilson J. M., Guiney D. G. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. N Engl J Med. 1982 Jan 7;306(1):16–20. doi: 10.1056/NEJM198201073060105. [DOI] [PubMed] [Google Scholar]
  17. Winston D. J., Ho W. G., Gale R. P. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982 Oct;97(4):509–515. doi: 10.7326/0003-4819-97-4-509. [DOI] [PubMed] [Google Scholar]
  18. van der Waaij D., Berghuis-de Vries J. M. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Lond) 1974 Apr;72(2):205–211. doi: 10.1017/s002217240002341x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. van der Waaij D., Berghuis J. M., Lekkerkerk J. E. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Lond) 1972 Dec;70(4):605–610. doi: 10.1017/s0022172400022464. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES